3 Houston innovators to know this week

Who's who

This week's innovators to know are all tech entrepreneurs with big ideas. Courtesy photos

From the science of love to confusing cryptocurrency, this week's Houston innovators to know are dabbling in some interesting industries to say the least.

Corey Allen, founder of Ecotone and treasurer of the Greater Houston LGBT Chamber

Corey Allen had entrepreneurialism in his blood — but it wasn't until he got involved with the Greater Houston LGBT Chamber that he got the courage to break out on his own. Courtesy of Corey Allen

This week's Pride Month feature is Corey Allen, who has an amazing storing into entrepreneurialism. He found confidence and encouragement from joining the LGBT chamber and started his own business. Now, he helps lead the organization as treasurer. Click here to read his Q&A with InnovationMap.

Brittany Barreto, CEO and co-founder of WeHaveChemistry

Brittany Barreto has expanded her DNA dating technology to a compatibility company named We Have Chemistry. Courtesy of WeHaveChemistry

As Brittany Barreto was working to use science to find singles love, she fielded many requests from couples who wanted in on the DNA compatibility tool she created. The requests kept coming in and now, Barreto has pivoted her dating app, Pheramor, to a new compatibility concept called WeHaveChemistry. Click here to read the full story.

Spencer Randall, principal and co-founder of CryptoEQ

Cryptocurrency doesn't have to be a big, confusing risk with this Houston startup's technology. Courtesy of CryptoEQ

Spencer Randall, through his new company CryptoEQ, wants to simplify ratings and analysis in cryptocurrency, which historically has been confusing and approachable to most. With the company's beta now live, Randall hopes that those not familiar with cryptocurrency will be able to use the platform as a learning tool. The platform takes information on trending cryptocurrency and boils it down into three columns — rating, technical analysis and trend analysis — in order for users to know when to buy or sell. Read the full story here.

Corey Allen had entrepreneurialism in his blood — but it wasn't until he got involved with the Greater Houston LGBT Chamber that he got the courage to break out on his own. Courtesy of Corey Allen

Houston entrepreneur explains how he's seen the city's LGBT and innovation communities evolve

Featured Innovator

Corey Allen grew up surrounded by entrepreneurship. His family owned several small businesses when he was growing up. But it took the support of his community to push him toward leadership.

From working in an accounting firm to dabbling in a few oil and gas companies, Allen's career trajectory changed when he joined the Greater Houston LGBT Chamber of Commerce. Within the organization, for which he serves as treasurer, he met other motivated entrepreneurs and was given the support needed to open his own business, Ecotone.

Allen spoke with InnovationMap about his career and the importance of the LGBTQ community in entrepreneurship.

InnovationMap: How does Houston differ from other cities in the U.S. in terms of technology and entrepreneurship? What makes Houston different?

Corey Allen: I think everybody does default to Austin, right? People believe that that's the only technology hub in Texas. Houston is new and different from other cities in terms of tech and entrepreneurship, right now especially. In creating three local startups, we experienced tremendous support from well-established groups like the Greater Houston Partnership, the city of Houston with the Mayor's entrepreneurship program, the Greater Houston Chamber of Commerce. But, you know, what I think what is really new especially for Texas, within in Houston, is the local coworking spaces that are globally recognized brands and the coding camps. I think that is what is creating the infrastructure and ecosystem that we've been talking about for the last five years at least. I think that compared to other cities in the U.S., I don't see that type of energy and that type of investment being created in Houston right now.

IM: You mentioned a little bit about being involved in the process of creating three local startups. What makes Houston the right place to be involved in the startup culture that’s cultivating right now?

CA: I think there's two things that come to mind. Houston really is home, and it's always been home for me. And it really is a big, small town. I came from a small town in Texas, about halfway between Houston and Dallas, and our family always navigated to Houston for fun, but also for business. It was really the foundation for my own family, and I think what we get out of Houston is that southern hospitality is a real thing. So, that's certainly the first thing. And the second is that Houston has the foundation for a prosperous ecosystem. Obviously, there's a lot of oil and gas and the Texas Medical Center is already globally recognized. The more that we continue to focus on venture capital and innovation, which is what is wanted and needed right now, Houston is creating our own new technology and entrepreneurship to capture everybody's attention.

IM: What are some of the ways the tech and innovation community support their LGBTQ colleagues throughout the month of June?

Yeah, I love this question. I think it goes without saying for the community to come out and support the LGBTQ community by joining the chamber of commerce. Also, attending our second annual Pride in Business, which is June 28. That's been an outstanding event for all of the businesses in the community to be involved in the LGBT community. In three years time, (the Greater Houston LGBT Chamber) has been growing exponentially to over 125 visible members. And we have corporate partnerships that really speak to the impact that is being made in the community and in Houston. We have corporate partners like Shell and United. And also celebrate and attend the Houston Pride Parade, which is on June 22.

IM: What advice do you have for up-and-coming lgbtq entrepreneurs?

CA: The learning is the action. I used to really be annoyed by the phrase "sell faster." I actually live that now. You can't fail until you act, and now I know that you can't compete until you fail.

IM: That's great advice right there. What does pride month mean to you?

CA: It's very personal, and it hits home. My partner and I are going to be celebrating 19 years together in September, and I think that pride means celebrating a history that we don't stop to think about everyday. We were at a chamber meeting recently, and a member was sharing her experience of walking in the second pride parade. And she said that it wasn't the same. Even the police at the time did not protect the community. And that's a big difference from today. And I think anybody that goes out to the pride parade this year, I want them to know they're safe. And you know, I think that that's what we have to be thankful for today is to know that we can love without constant fear. It really just reminds us that we're not going to let anyone take that away again.

------

Portions of this interview have been edited.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Greentown Labs names Lawson Gow as its new Houston leader

head of hou

Greentown Labs has named Lawson Gow as its Head of Houston.

Gow is the founder of The Cannon, a coworking space with seven locations in the Houston area, with additional partner spaces. He also recently served as managing partner at Houston-based investment and advisory firm Helium Capital. Gow is the son of David Gow, founder of Energy Capital's parent company, Gow Media.

According to Greentown, Gow will "enhance the founder experience, cultivate strategic partnerships, and accelerate climatetech solutions" in his new role.

“I couldn’t be more excited to join Greentown at this critical moment for the energy transition,” Gow said in a news release. “Greentown has a fantastic track record of supporting entrepreneurs in Houston, Boston, and beyond, and I am eager to keep advancing our mission in the energy transition capital of the world.”

Gow has also held analyst, strategy and advising roles since graduating from Rice University.

“We are thrilled to welcome Lawson to our leadership team,” Georgina Campbell Flatter, CEO of Greentown Labs, added in the release. “Lawson has spent his career building community and championing entrepreneurs, and we look forward to him deepening Greentown’s support of climate and energy startups as our Head of Houston.”

Gow is the latest addition to a series of new hires at Greentown Labs following a leadership shakeup.

Flatter was named as the organization's new CEO in February, replacing Kevin Dutt, Greentown’s interim CEO, who replaced Kevin Knobloch after he announced that he would step down in July 2024 after less than a year in the role.

Greentown also named Naheed Malik its new CFO in January.

Timmeko Moore Love was named the first Houston general manager and senior vice president of Greentown Labs. According to LinkedIn, she left the role in January.

---

This article originally appeared on our sister site, EnergyCapitalHTX.com.

Houston foundation grants $27M to support Texas chemistry research

fresh funding

Houston-based The Welch Foundation has doled out $27 million in its latest round of grants for chemical research, equipment and postdoctoral fellowships.

According to a June announcement, $25.5 million was allocated for the foundation's longstanding research grants, which provide $100,000 per year in funding for three years to full-time, regular tenure or tenure-track faculty members in Texas. The foundation made 85 grants to faculty at 16 Texas institutions for 2025, including:

  • Michael I. Jacobs, assistant professor in the chemistry and biochemistry department at Texas State University, who is investigating the structure and thermodynamics of intrinsically disordered proteins, which could "reveal clues about how life began," according to the foundation.
  • Kendra K. Frederick, assistant professor in the biophysics department at The University of Texas Southwestern Medical Center, who is studying a protein linked to Parkinson’s disease.
  • Jennifer S. Brodbelt, professor in chemistry at The University of Texas at Austin, who is testing a theory called full replica symmetry breaking (fullRSB) on glass-like materials, which has implications for complex systems in physics, chemistry and biology.

Additional funding will be allocated to the Welch Postdoctoral Fellows of the Life Sciences Research Foundation. The program provides three-year fellowships to recent PhD graduates to support clinical research careers in Texas. Two fellows from Rice University and Baylor University will receive $100,000 annually for three years.

The Welch Foundation also issued $975,000 through its equipment grant program to 13 institutions to help them develop "richer laboratory experience(s)." The universities matched funds of $352,346.

Since 1954, the Welch Foundation has contributed over $1.1 billion for Texas-nurtured advancements in chemistry through research grants, endowed chairs and other chemistry-related ventures. Last year, the foundation granted more than $40.5 million in academic research grants, equipment grants and fellowships.

“Through funding basic chemical research, we are actively investing in the future of humankind,” Adam Kuspa, president of The Welch Foundation, said the news release. “We are proud to support so many talented researchers across Texas and continue to be inspired by the important work they complete every day.”

New Houston biotech co. developing capsules for hard-to-treat tumors

biotech breakthroughs

Houston company Sentinel BioTherapeutics has made promising headway in cancer immunotherapy for patients who don’t respond positively to more traditional treatments. New biotech venture creation studio RBL LLC (pronounced “rebel”) recently debuted the company at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

Rima Chakrabarti is a neurologist by training. Though she says she’s “passionate about treating the brain,” her greatest fervor currently lies in leading Sentinel as its CEO. Sentinel is RBL’s first clinical venture, and Chakrabarti also serves as cofounder and managing partner of the venture studio.

The team sees an opportunity to use cytokine interleukin-2 (IL-2) capsules to fight many solid tumors for which immunotherapy hasn't been effective in the past. “We plan to develop a pipeline of drugs that way,” Chakrabarti says.

This may all sound brand-new, but Sentinel’s research goes back years to the work of Omid Veiseh, director of the Rice Biotechnology Launch Pad (RBLP). Through another, now-defunct company called Avenge Bio, Veiseh and Paul Wotton — also with RBLP and now RBL’s CEO and chairman of Sentinel — invested close to $45 million in capital toward their promising discovery.

From preclinical data on studies in mice, Avenge was able to manufacture its platform focused on ovarian cancer treatments and test it on 14 human patients. “That's essentially opened the door to understanding the clinical efficacy of this drug as well as it's brought this to the attention of the FDA, such that now we're able to continue that conversation,” says Chakrabarti. She emphasizes the point that Avenge’s demise was not due to the science, but to the company's unsuccessful outsourcing to a Massachusetts management team.

“They hadn't analyzed a lot of the data that we got access to upon the acquisition,” explains Chakrabarti. “When we analyzed the data, we saw this dose-dependent immune activation, very specific upregulation of checkpoints on T cells. We came to understand how effective this agent could be as an immune priming agent in a way that Avenge Bio hadn't been developing this drug.”

Chakrabarti says that Sentinel’s phase II trials are coming soon. They’ll continue their previous work with ovarian cancer, but Chakrabarti says that she also believes that the IL-2 capsules will be effective in the treatment of endometrial cancer. There’s also potential for people with other cancers located in the peritoneal cavity, such as colorectal cancer, gastrointestinal cancer and even primary peritoneal carcinomatosis.

“We're delivering these capsules into the peritoneal cavity and seeing both the safety as well as the immune activation,” Chakrabarti says. “We're seeing that up-regulation of the checkpoint that I mentioned. We're seeing a strong safety signal. This drug was very well-tolerated by patients where IL-2 has always had a challenge in being a well-tolerated drug.”

When phase II will take place is up to the success of Sentinel’s fundraising push. What we do know is that it will be led by Amir Jazaeri at MD Anderson Cancer Center. Part of the goal this summer is also to create an automated cell manufacturing process and prove that Sentinel can store its product long-term.

“This isn’t just another cell therapy,” Chakrabarti says.

"Sentinel's cytokine factory platform is the breakthrough technology that we believe has the potential to define the next era of cancer treatment," adds Wotton.

View All Listings